000 | 01962 a2200613 4500 | ||
---|---|---|---|
005 | 20250517103115.0 | ||
264 | 0 | _c20160707 | |
008 | 201607s 0 0 eng d | ||
022 | _a1533-4406 | ||
024 | 7 |
_a10.1056/NEJMc1515403 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChandesris, Marie-Olivia | |
245 | 0 | 0 |
_aMidostaurin in Advanced Systemic Mastocytosis. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cJun 2016 |
||
300 |
_a2605-7 p. _bdigital |
||
500 | _aPublication Type: Controlled Clinical Trial; Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAge of Onset |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMastocytosis, Systemic _xdrug therapy |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aStaurosporine _xadverse effects |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aDamaj, Gandhi | |
700 | 1 | _aCanioni, Danielle | |
700 | 1 | _aBrouzes, Chantal | |
700 | 1 | _aLhermitte, Ludovic | |
700 | 1 | _aHanssens, Katia | |
700 | 1 | _aFrenzel, Laurent | |
700 | 1 | _aCherquaoui, Zoubair | |
700 | 1 | _aDurieu, Isabelle | |
700 | 1 | _aDurupt, Stéphane | |
700 | 1 | _aGyan, Emmanuel | |
700 | 1 | _aBeyne-Rauzy, Odille | |
700 | 1 | _aLaunay, David | |
700 | 1 | _aFaure, Cyril | |
700 | 1 | _aHamidou, Mohamed | |
700 | 1 | _aBesnard, Sophie | |
700 | 1 | _aDiouf, Momar | |
700 | 1 | _aSchiffmann, Aurélie | |
700 | 1 | _aNiault, Mathilde | |
700 | 1 | _aJeandel, Pierre-Yves | |
700 | 1 | _aRanta, Dana | |
700 | 1 | _aGressin, Remi | |
700 | 1 | _aChantepie, Sylvain | |
700 | 1 | _aBarete, Stéphane | |
700 | 1 | _aDubreuil, Patrice | |
700 | 1 | _aBourget, Philippe | |
700 | 1 | _aLortholary, Olivier | |
700 | 1 | _aHermine, Olivier | |
773 | 0 |
_tThe New England journal of medicine _gvol. 374 _gno. 26 _gp. 2605-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc1515403 _zAvailable from publisher's website |
999 |
_c26171941 _d26171941 |